Anabolic-androgenic steroids: a possible new risk factor of toxicant-associated fatty liver disease.
Schwingel
Paulo Adriano
PA
Programa de Pós-Graduação em Medicina e Saúde (PPgMS), Faculdade de Medicina da Bahia, Universidade Federal da Bahia (UFBA), Salvador, Bahia, Brazil.
Cotrim
Helma P
HP
Salles
Bernardo Rios
BR
Almeida
Carlos Eduardo
CE
dos Santos
Crimério Ribeiro
CR
Nachef
Bruno
B
Andrade
Antonio Ricardo
AR
Zoppi
Cláudio C
CC
D000328:Adult; D045930:Anabolic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D000728:Androgens / Q000008:administration & dosage / Q000009:adverse effects*; D001938:Brazil / Q000453:epidemiology; D016022:Case-Control Studies; D056486:Chemical and Drug Induced Liver Injury / Q000097:blood / Q000453:epidemiology / Q000209:etiology*; D005234:Fatty Liver / Q000453:epidemiology / Q000209:etiology; D006801:Humans; D007273:Injections, Intramuscular; D007333:Insulin Resistance / Q000502:physiology; D008099:Liver / Q000187:drug effects*; D008297:Male; D065626:Non-alcoholic Fatty Liver Disease; D058573:Performance-Enhancing Substances / Q000009:adverse effects*; D013177:Sports; D019966:Substance-Related Disorders / Q000453:epidemiology / Q000209:etiology; D000637:Transaminases / Q000097:blood; D055815:Young Adult
D045930:Anabolic Agents; D000728:Androgens; D058573:Performance-Enhancing Substances; D000637:Transaminases